Abstract
Diabetes can be associated with development or worsening of frailty and sarcopenia via insulin resistance, inflammation or hyperglycemia, and U-shaped association is observed between HbA1c and frailty. In the management of diabetes, resistance training, nutritional support and some of the antidiabetic agents can slow the progression of frailty and sarcopenia. In the management of hypertension, intensive blood pressure lowering can lead to worse outcomes in older adults with severe frailty. The inhibitors of renin-angiotensin system can slow the progression of frailty and sarcopenia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
